quote
February 22 Short Course
February 23-25 Conference Workshops
  Bioanalysis
  Biotransformation
SESSION TOPIC SPEAKER COMPANY TIME
Registration       07:45- 08:30
  Welcome address     08:30-08:35
  Conference: Introduction     08:35-08-40
  Conference: Opening Remarks     08-40-08-45
Plenary Speaker I       08:45 - 09:30
Plenary Speaker II       9:30 - 10:15
Session I: Bioanalysis : Large & Small Molecules
     Surendra Bansal (Invited)  Roche, USA 10:15 - 10:45
        10:45 - 11:15
Break       11:15 - 11:30
        11:30 - 12:00
        12:00 - 12:30
Panel Discussion       12:30 - 12:45
Lunch Break       12:45 - 1:45
Session II: Method development & Sample Preparation
   Handling of endogenous compounds: Bioanalytical challenges-case studies     1:45 - 2:15
        2:15 - 2:45
        2:45 - 3:15
Panel Discussion       3:15 - 3:30
Break       3:30 - 3:45
Session III: Bioanalysis: Newer Technologies
        3:45- 4:15
        4:15- 4:45
 Session IV:  Bioanalysis: Regulatory Aspects      
   Recent update and current trends in regulatory guidelines     5:15 - 5:25
     Enaksha Wikremsinhe (Webinar)  Eli Lilly, USA 5:25 - 5:55
        5:55 - 6:15
Evening snacks/mocktail Reception 7:00 - 8:00
 
SESSION TOPIC SPEAKER COMPANY TIME
         
Session Introduction       8:25 - 8:30
Plenary       8:30 - 9:15
Session I: Drug Discovery-Preclinical Phase
  Session I Introduction     9:15 - 9:20
     Punit Marathe  BMS, USA 9:20 - 9:55
        9:55 - 10:30
  Panel Discussion     10:30 - 10:50
Break       10:50 - 11:05
Session II: Large Molecule Bioanalysis
Session Introduction       11:05 - 11:10
     Tim Olah  BMS, USA 11:10 - 11:45
        11:45 - 12:20
Agilent Presentation       12:20 - 12:55
Panel Discussion       12:55 - 1:30
Lunch       1:30 - 2:30
Session III: Small Molecules Bioanalysis & Sample Preparation
Session III Introduction       2:30 - 2:35
 

 

 Stacy Ho (Invited)  Genzyme 2:35 - 3:05
 

 

    3:05 - 3:40
        3:40 - 4:15
Panel Discussion       4:15 - 4:20
Break       4:20 - 4:35
Session IV  Newer Technologies/Tissue Bioanalysis      
Sessions IV Introduction    Jonathan Josephs  Thermo, USA 4:35 - 4:40
        4:40 - 5:25
        5:25 - 6:00
Panel Discussion Session IV speakers     6:00 - 6:20
Wrap Up       6:20 - 6:30
Poster Presentation & Evening snacks/ Mocktail Reception 6:30 - 8:00
SESSION TOPIC SPEAKER COMPANY TIME
         
Session Introduction       08:25-08:30
Keynote 1       8:30 - 9:15
Keynote 2       9:15 - 10:00
Session I: Recent Advances : BTX pathaways
Session I Introduction       10:00 - 10:05
   Unusual Biotransformation Pathways
 Kaushik Mitra  Merck, USA 10:05 - 10:35
   Advanced in vitro technologies to predict human metabolism & metabolites, Structure based metabolism predictions  Deepak Dalvie  Pfizer, USA 10:35 - 11:05
Panel Discussion       11:05 - 11:30
Break       11:30 - 11:45
Session II-  Metabolite coverage and Safety evaluation
Session II Introduction        
   How to handle a disproportionate metabolite (MIST)     11:45 - 12:15
   Metabolite DDI     12:15 - 12:45
Vendor Presentation       12:45 - 1:15
Lunch       1:15 - 2:15
Session III- 
Session III Introduction  Translation of invitro DDI liability into clinic     2:15 - 2:20
   How to translate in vitro DDI liabilities in early discovery to clinical DDI: Utility of modelling and simulations     2:20 - 2:50
     Rama Iyer BMS, USA  2:50 - 3:20
   Muclear Receptors and CYP Induction     3:20 - 3:50
     Dr.Nilima Kshirsagar ICMR, India 3:50 - 4:20
Panel Discussion       4:20 - 4:35
Break       4:35 - 4:50
Session IV-   Transporters      
Session IV Introduction       4:50- 4:55
        4:55 - 5:25
APA India 2015 Concluding remarks 5.15